Achieve Life Sciences, Inc. (ACHV)

NASDAQ

$6.80

$-0.02

(-0.29%)

Pre-Market

Achieve Life Sciences, Inc. (ACHV) Live Price Chart

Last updated: ⁦2026-10-20 10:38:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Achieve Life Sciences, Inc. (ACHV) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $6.80, with a market capitalization of $657.79M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.62 to $8.64. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$657.79M
Open	$6.82
Day's High	$970.00
Day's Low	$1.84
Previous Close	$6.61
Volume	29.00
Average Volume	1.41M
P/E Ratio	--
52-Week High	$8.64
52-Week Low	$2.62
Dividend Yield	--
Earnings Date	--

Achieve Life Sciences, Inc. (ACHV) Pre-Market Stock Price

Achieve Life Sciences, Inc. (ACHV) is trading at $6.80 in pre-market trading as of 2026-10-20 09:58:00, up 2.97% ($0.20) from the previous close of $6.61

Pre-market trading shows how investors are pricing ACHV before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Achieve Life Sciences, Inc. (ACHV) 7-Day Stock Price Change

Over the past seven days, Achieve Life Sciences, Inc. (ACHV) moved from $7.41 to $6.80, representing a decline of 8.22% ($0.61).

The stock traded between $6.22 and $7.48 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 1.32 million shares, down versus the previous seven-day period, indicating lower trading activity.

ACHV 52-Week Price Position

Position in Range: 69.5%

52W Low$2.62

52W High$8.64

ACHV is currently trading at $6.80, placing it 69.5% of the way from its 52-week low of $2.62 to its 52-week high of $8.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Achieve Life Sciences, Inc. (ACHV)?

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Achieve Life Sciences, Inc. Information

Industry	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees	28
Exchange	NASDAQ
Company Website	https://www.achievelifesciences.com

How to Buy Achieve Life Sciences, Inc. (ACHV) Stock on MEXC

Eligible investors can buy real shares of Achieve Life Sciences, Inc. (ACHV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ACHV and Place Your Order

Open the RealStocks trading page and search for ACHV. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Achieve Life Sciences, Inc. (ACHV) stock price today?

Achieve Life Sciences, Inc. (ACHV) is currently trading at $ 6.80, up 2.97% ($0.20) from the previous close of $ 6.61. Intraday prices update in real time during regular trading hours.

2.Is ACHV stock going up or down today?

As of 2026-10-20 09:58:00, ACHV is trading at $ 6.80, up 2.97% ($0.20) from its previous close of $ 6.61. The stock has traded between $ 1.84 and $ 970.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is ACHV pre-market price?

As of 2026-10-20 09:58:00, ACHV is trading at $ 6.80 in pre-market trading, up 2.97% ($0.20) from the previous close of $ 6.61. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ACHV after-hours price?

As of 2026-10-20 09:58:00, ACHV is trading at $ 6.82 in after-hours trading, up 3.32% ($0.22) from the regular-session close of $ 6.61. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ACHV stock trading now?

ACHV trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ACHV sit relative to its 52-week high and low?

Over the past 52 weeks, ACHV has traded between a low of $ 2.62 and a high of $ 8.64. At $ 6.80, the stock is positioned 69.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Achieve Life Sciences, Inc. in?

Achieve Life Sciences, Inc. (ACHV) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Achieve Life Sciences, Inc.'s market capitalization and where is it listed?

Achieve Life Sciences, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 657.79M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ACHV valued in terms of P/E ratio and EPS?

ACHV trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.11. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Achieve Life Sciences, Inc. pay a dividend?

Achieve Life Sciences, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.